Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-28

FDA Approved: DHIVY — Supplemental Application (Avion Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for DHIVY, a carbidopa-levodopa product from Avion Pharmaceuticals, LLC. The action approves changes under the NDA as de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DHIVY (Carbidopa/Levodopa)

Snippet

SUPPL AP for DHIVY (CARBIDOPA LEVODOPA)